ScholarMate
English简体中文繁體中文
客服熱線:400-1616-289
登入註冊
期刊論文

A patient with refractory proliferative lupus nephritis treated with telitacicept: A case report

Chen, Jing-Wen; Zhan, Jing-Yi; Liang, Si-Ping; Wang, Xiao-Dan; Lin, Chang-Song*; Xu, Qiang*广州中医药大学; 广东食品药品职业学院; 1
International Journal of Rheumatic Diseases2023-7DOI: 10.1111/1756-185X.14752
4被引4閱讀
引用收藏
分享

摘要

IntroductionSystemic lupus erythematosus (SLE) is a chronic autoimmune disease. Lupus nephritis (LN) is a common type of organ damage which occurs in SLE patients and is characterized by recurrent proteinuria. Activation of B lymphocytes can lead to refractory LN, which is an important pathogenic factor in SLE. B lymphocyte stimulator (BLyS) and A proliferation-inducing ligand (APRIL) are predominantly produced by myeloid cells (monocytes, dendritic cells, neutrophils, etc) to regulate B lymphocyte function. Telitacicept was the first dual-targeting biological drug which targeted both BLyS and APRIL. Telitacicept has passed a phase II clinical trial and has since been approved for the treatment of SLE. Case PresentationWe report a case of SLE confirmed by renal biopsy as proliferative lupus nephritis (PLN) with massive proteinuria, which was treated with telitacicept (European League Against Rheumatism / American College of Rheumatology 2019 standard). During the 19 months of follow-up, the patient's renal function was stable, massive proteinuria was relieved, and creatinine and blood pressure did not increase. ConclusionsDuring the 19 months of telitacicept treatment (160 mg once weekly), PLN reduced blood system damage and proteinuria without increasing the risk of infection.

學科與關鍵詞

關鍵詞
APRILB-cell lymphocyte stimulatorproliferative lupus nephritissystemic lupus erythematosustelitacicept
相關
載入中…

文獻載入失敗,請重試

重試

發表資訊

論文狀態
公開發表
期刊
International Journal of Rheumatic Diseases
發表日期
2023-07
卷期
第 26 卷, 第 7 期
頁碼
1417-1421
DOI
10.1111/1756-185X.14752
語言
ENGLISH
成果收錄
SCIE

作者

  • C

    Chen, Jing-Wen (第一作者)

    1 · guangzhou univ chinese med

  • Z

    Zhan, Jing-Yi

    1 · guangzhou univ chinese med

查看全部 6 位作者收起作者
  • L

    Liang, Si-Ping

    1 · guangzhou univ chinese med

  • W

    Wang, Xiao-Dan

    guangdong food & drug vocat coll

  • L

    Lin, Chang-Song (通訊)

    1 · guangzhou univ chinese med

  • X

    Xu, Qiang (通訊)

    1 · guangzhou univ chinese med

登入解鎖更多功能

  • 收藏這篇,隨時在「我的 · 收藏」找回
  • 認領你的成果,生成推廣素材
  • 關注作者獲取最新成果
  • 加入項目組、協同寫作
註冊 / 登入

產品服務

  • 科研之友
  • 創新城
  • 科創雲

服務支援

  • 幫助中心
  • 隱私政策
  • 服務條款

聯絡方式

線上客服:【】
客服熱線:400-1616-289
電子郵件:support@scholarmate.com

關注或下載科研之友

微信 QR Code
微信公眾號
客戶端下載 QR Code
下載客戶端
科研成果科研人員科研機構科研動態愛瑞思軟件

©2026 深圳市科研之友网络服务有限公司

公安備案圖示粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417